131 related articles for article (PubMed ID: 16779734)
1. Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro.
Martinez LR; Christaki E; Casadevall A
J Infect Dis; 2006 Jul; 194(2):261-6. PubMed ID: 16779734
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Martinez LR; Casadevall A
Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
Nooney L; Matthews RC; Burnie JP
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):19-29. PubMed ID: 15629225
[TBL] [Abstract][Full Text] [Related]
4. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
Franzot SP; Casadevall A
Antimicrob Agents Chemother; 1997 Feb; 41(2):331-6. PubMed ID: 9021188
[TBL] [Abstract][Full Text] [Related]
5. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy.
Martinez LR; Casadevall A
Infect Immun; 2005 Oct; 73(10):6350-62. PubMed ID: 16177306
[TBL] [Abstract][Full Text] [Related]
6. Darunavir inhibits
Brilhante RSN; Silva JAT; Araújo GDS; Pereira VS; Gotay WJP; Oliveira JS; Guedes GMM; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
J Med Microbiol; 2020 Jun; 69(6):830-837. PubMed ID: 32459616
[No Abstract] [Full Text] [Related]
7. Biofilm Formation by Cryptococcus neoformans.
Martinez LR; Casadevall A
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185073
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Khyriem AB; Sujatha S; Parija SC
Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins.
Maligie MA; Selitrennikoff CP
Antimicrob Agents Chemother; 2005 Jul; 49(7):2851-6. PubMed ID: 15980360
[TBL] [Abstract][Full Text] [Related]
10. Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.
Pettit RK; Repp KK; Hazen KC
Med Mycol; 2010 Mar; 48(2):421-6. PubMed ID: 19637092
[TBL] [Abstract][Full Text] [Related]
11. Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.
de Aguiar Cordeiro R; Mourão CI; Rocha MF; de Farias Marques FJ; Teixeira CE; de Oliveira Miranda DF; Neto LV; Brilhante RS; de Jesus Pinheiro Gomes Bandeira T; Sidrim JJ
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):557-64. PubMed ID: 23192488
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.
Martinez LR; Casadevall A
Infect Immun; 2006 Nov; 74(11):6118-23. PubMed ID: 17057089
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.
Shuford JA; Rouse MS; Piper KE; Steckelberg JM; Patel R
J Infect Dis; 2006 Sep; 194(5):710-3. PubMed ID: 16897672
[TBL] [Abstract][Full Text] [Related]
14. The Antimicrobial Peptide MK58911-NH
Singulani JL; Oliveira LT; Ramos MD; Fregonezi NF; Gomes PC; Galeane MC; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0090421. PubMed ID: 34516241
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans.
Pereira TC; de Menezes RT; de Oliveira HC; de Oliveira LD; Scorzoni L
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33417701
[TBL] [Abstract][Full Text] [Related]
16. The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans.
Feldmesser M; Kress Y; Mednick A; Casadevall A
J Infect Dis; 2000 Dec; 182(6):1791-5. PubMed ID: 11069257
[TBL] [Abstract][Full Text] [Related]
17. Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection.
Zaragoza O; Mihu C; Casadevall A; Nosanchuk JD
Antimicrob Agents Chemother; 2005 Oct; 49(10):4358-61. PubMed ID: 16189121
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
[TBL] [Abstract][Full Text] [Related]
19. In vitro interaction of antifungal and antibacterial drugs against Cryptococcus neoformans var. grubii before and after capsular induction.
Rossato L; Loreto ÉS; Venturini TP; Azevedo MI; Weiblen C; Botton SA; Santurio JM; Alves SH
Med Mycol; 2015 Nov; 53(8):885-9. PubMed ID: 26333356
[TBL] [Abstract][Full Text] [Related]
20. In vitro synergism of concentrated Allium sativum extract and amphotericin B against Cryptococcus neoformans.
Davis LE; Shen J; Royer RE
Planta Med; 1994 Dec; 60(6):546-9. PubMed ID: 7809209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
